Superluminal Medicines, Inc.
New Form D on file · 2026-09-03 · the record
Bar compares stated amounts only. A raise with no amount on the record is left out rather than counted as zero.
Open the record →What the record says
| Named | Relationship on the filing | Where |
|---|---|---|
| CONY D'CRUZ | Executive Officer, Director, Promoter | BOSTON, MASSACHUSETTS |
| NANDITA SHANGARI | Director | BOSTON, MASSACHUSETTS |
| DYLAN MORRIS | Director | BOSTON, MASSACHUSETTS |
| DIAMANTIS XYLAS | Director | BOSTON, MASSACHUSETTS |
| HARSHA PALADUGU | Director | BOSTON, MASSACHUSETTS |
A Form D names the people responsible for the offering, not a team page — there are no photographs or profiles on it, so none are shown.
Against the 5 raises on file in Biotechnology. Median $5.09M, largest $65.48M.
The nearest raises on file in the same industry group (Biotechnology), side by side with this one.
| Company | On the record | Industry group | Filed |
|---|---|---|---|
| Gossamer Bio, Inc. | $25M | Biotechnology | 2026-09-04 |
| Episteme Prognostics, Inc. | $5.09M | Biotechnology | 2026-09-04 |
| Episteme Prognostics, Inc. | $5.09M | Biotechnology | 2026-09-04 |
| Pluri Inc. | $3.68M | Biotechnology | 2026-09-04 |
| Superluminal Medicines, Inc. (this page) | $65.48M | Biotechnology | 2026-09-03 |
Click a column heading to sort. Comparison is against records held here, not against every raise that exists. A raise with no stated amount shows as "Not stated" rather than as zero.
The full profile
The rest of this profile is open on any paid or trial plan
It costs no credits. It is a plan check and nothing else.
- Source Check — verify Cony DCruz's other claims against the registers that hold them.
- INVEST — compare this raise against the peers above, on the numbers.
- RECRUIT — see who is already on the team.
- Press Requests — connect with Cony DCruz for a story.
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Superluminal Medicines, Inc.You get an alert in MentionFox the next time this company shows up.
Is this you?
If you're behind Superluminal Medicines, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. FoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov. Figures are read directly from the source record; names have not been matched against other people.